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Objectives: to report a 6 year experience with carotid percutaneous transluminal angioplasty (CPTA) in a selected group
of patients.
Material and Method: we retrospectively reviewed our experience after performing 54 CPTAs, with (n=18) or without
(n=36) stent deployment, over a period of 6 years from 1993 to 1999. All patients, except one, suffered from focal
hemispheric neurologic symptoms. During the same time period 284 patients underwent carotid endarterectomy. The
selection of the 54 patients (16%) for CPTA was based on the carotid angiogram and the sole inclusion criterion for
endovascular treatment was a short, concentric, and smooth stenosis of more than 70% without ulceration or severe
calcification. All patients who had a patent internal carotid artery after the last control were invited for a clinical duplex
examination and all duplex examinations were carried out by a single experienced observer.
Results: early outcome (<30 days): CPTA was judged technically successful in 50 cases (93%). Ten patients (18%)
experienced a neurological event in relation to the procedure and one patient (2%) suffered a major stroke. One stent
occluded within 30 days. Late outcome: Forty-six patients (85%) entered the follow-up study after a median of 34 months
(range 1–80 months). Six patients (13%) had recurrent symptoms. The colour-duplex examination (n=45) showed
internal carotid artery occlusion in 2 patients (5%), and restenosis (>70%) in 10 patients (22%). We found no significant
difference in the reoccurrence of neurological symptoms or the rate of restenosis between patients treated with and without
stent (Log Rank 0.28, p=0,59). ICA was patent without restenosis in 60% after 48 months in patients treated with
CPTA alone, and in 76% after 3 months in patients treated with a stent (N.S.).
Conclusion: CPTA in a selected group of patients has a mortality and major stroke rate comparable to that of carotid
endarterectomy. However, the risk of transient neurological events was high, as well as the incidence of restenosis (>70%)
after 3 years. We still consider CPTA an experimental procedure. The indications for this treatment must be clarified if
CPTA should be an alternative to surgery with a comparable neurological complication rate.
Introduction renal, iliac, superficial femoral and popliteal arteries.
During the last decade PTA has also been used to
treat occlusive atherosclerotic disease in the ICA.3 ThisStroke is one of the leading causes of death in the
treatment was introduced in Scandinavia in 19934,5 butwestern world.1 The risk of stroke relates to the pres-
is still not considered a routine procedure probablyence of severe arteriosclerotic lesions in the common
because reliable long-term results and well definedand internal carotid artery (ICA) and may be reduced
treatment guidelines are missing. The immediate be-if such lesions are removed. Currently, carotid thromb-
nefits of carotid PTA (CPTA) vs CEA include shortendarterectomy (CEA) is the treatment of choice in
treatment duration, no need of general anaesthesiasevere (>70%) symptomatic stenoses in the ICA be-
and avoidance of surgical stress as well as possiblecause it reduces the risk of ipsilateral stroke by 17%
complications following surgical treatment, e.g. peri-after 2 years.2
pheral nerve lesions and haemorrage. Despite the lackPercutaneous transluminal angioplasty (PTA) with
of clear evidence, it is assumed that the perioperativeor without stent deployment is an established treat-
mortality and morbidity following CPTA is com-ment of occlusive atherosclerotic disease in coronary,
parable with CEA.1 The purpose of this retrospective
investigation was to evaluate safety and efficiency of
∗ Please address all correspondence to: J.-F. Baudier, Department of
CPTA in a selected group of patients with significantVascular Surgery, Odense University Hospital, DK-5000 Odense C,
Denmark. (>70%) stenosis of the ICA.
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Material and Methods PTA, while 18 (33%) also had a stent deployed. After
endovascular treatment all patients were observed
During the time when this study was undertaken for 3–4 days, and continuously treated with ASA
(100–150 mg/day) or ASA (100–150 mg/day) and di-patients suspected of having a symptomatic ICA sten-
osis were referred to the Department of Neurology pyridamol (200 mg/day).
During the introduction of this new treatment stentswhere they were screened by transcranial Doppler or
by duplex scanning. If a symptomatic stenosis was were only used in case of residual stenosis (>50%) and
recoil (n=1), dissection or significant irregularities ofsuspected the patient was referred to angiography.
During the period May 1993–October 1999 ap- the artery wall after PTA (n=7). After July 1998 stents
were used more routinely. Three different types wereproximately 600 patients underwent angiography. The
indication for surgical or endovascular treatment, was used: the balloon-expandable Palmaz stent (Johnson &
Johnson) (n=7), the self-expandable Easy Wallstenta high-grade stenosis (>70%) on angiography which
was found in 338 patients. The inclusion criteria for (Schneider) (n=10) and the self-expandable Multilink
stent (ACS) (n=1). Two lesions were treated withCPTA were sharply defined based exclusively on
angiography: the stenosis had to be short (<1 cm), double stents.
Neurological events during and immediately afterconcentric, smooth, and without ulceration or severe
calcification to provide optimal treatment conditions treatment were recorded in three categories: (1) TIA
and amaurosis fugax which resolved within 24 h; (2)for the balloon procedure. Fifty-four ICAs were treated
with CPTA in 54 (16%) patients and 284 (84%) patients minor stroke causing minimal neurological deficit
without loss of the functional ability which resolvedunderwent CEA. The indication for endovascular treat-
ment in one case, however, was an asymptomatic 95% within 30 days and (3) major stroke defined as deficits
lasting more than 30 days with changes in the lifestylestenosis in the left ICA in a patient who was treated
prior to coronary artery bypass surgery. Fifty-three of the patient.6
Twenty-three of the first 24 patients were followed-patients had an atherosclerotic lesion and one patient
had a stenosis secondary to irradiation of the neck for up with duplex scanning and clinical examination in
1997.4 Thus, the present study includes all the patientstonsillary cancer. Male/female ratio was 37/17 and
the median age was 64 years (range 36–78). Thirty- from the former study with patent ICA in 1997 (n=23)
and, in addition, patients treated succesfully betweenone (57%) patients were smokers, 20 (37%) were treated
with antihypertensive medication, 13 (24%) had isch- 1997 and November 1999 (n=30). Forty-six patients
(85%) participated in a clinical examination and 45aemic heart disease, 10 (19%) had intermittent clau-
dication, 5 (9%) had diabetes mellitus and 5 (9%) were patients (83%) also underwent a colour duplex re-
examination at the beginning of the year 2000. Onetreated for hypercholesterolaemia.
All patients except one had a symptomatic severe patient was evaluated clinically only, and eight did
not participate in the follow-up: one patient had diedlesion (>70%) in the ICA: 11 patients suffered from
amaurosis fugax (20%), 8 of which (15%) also had due to pancreatic cancer, two refused to participate,
three were treated with CEA after CPTA because oftransitoric ischaemic attacks (TIA), 13 (24%) patients
had isolated TIA, and 21 (39%) patients had suffered recurrence of a symptomatic stenosis and one had an
occluded ICA. In the last patient CPTA of a restenosisfrom a minor stroke. Preoperative angiography dem-
onstrated a stenosis greater than 90% in 40 (74%) in the ICA one year after CEA was technically un-
succesful and the patient is presently treated medicallypatients and a stenosis between 71% and 89% in 14
(26%) patients. The criteria for assessment of the sten- with aspirin and dipyridamol.
Duplex scanning was performed with the patientsosis in the ICA were the same as used in the NASCET
study. in supine position. All examinations were performed
by the same experienced physician. We used a SiemensAll the patients received aspirin (ASA)
(100–150 mg×1) or ASA and dipyridamole Sonoline Elegra ultrasound system with a 5 Mhz lin-
ear array transducer and the angle of insonation never(200 mg×2) prior to angiography. All were cath-
eterised through the femoral artery. Heparin (5000 IU) exceeded 55°. ICA stenosis were evaluated according
to the criteria of Zweibel.7 For a stenosis of 60–79%was administrated intraarterially immediately prior to
CPTA. The size of the PTA balloon matched the normal the reference values were a peak velocity >130 cm/
sec, end-diastolic velocity >40 cm/sec, systolic velocityICA diameter distal to the stenosis and ranged from
3–6 mm. We considered the PTA procedure technically ratio (ICA/CCA) >1.8 and diastolic velocity ratio
(ICA/CCA) >2.4. For a stenosis of 80–99% the referencesuccesfull if any residual stenosis was less than 50%.
Thirty six (67%) lesions were treated exclusively with values were a peak velocity >250 cm/sec, end-diastolic
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velocity >100 cm/sec, systolic velocity ratio (ICA/ four of the symptomatic patients (9% of all examined
patients) had a significant restenosis (>70%) in theCCA) >3.7 and diastolic velocity ratio (ICA/CCA)
>5.5. treated ICA while there was no restenosis in two
patients. The latter two patients had a history of isch-Statistical analysis included calculation of the re-
stenosis-free interval by means of Kaplan–Meier sur- aemic heart disease with arrythmias.
Overall, in the 45 patients who underwent colourvival analysis using the intention to treat principle.
The two groups were compared using the Log Rank duplex scanning we found a stenosis between 50%
and 70% in 6 patients (13%), significant restenosismethod.
(>70%) in ten (22%) and ICA occlusion in two patients
(5%). The incidence of significant restenosis during
the follow-up in patients treated with or without stent
Results deployment was 13% and 25%, respectively. If oc-
clusions were included the incidence rates would be
Early outcome (<30 days) 20% and 29%, respectively. Furthermore, the median
follow up time in the former group was considerably
CPTA with or without stent, was primarily technically shorter than in the latter (44 months vs 14 months).
successful in 50 (93%) patients. Control angiography All patients except three (the one who died and the
showed a minor residual stenosis (<50%) in seven two who refused to participate) were included in a
(13%) patients. CPTA was not technically possible in Kaplan–Meier survival analysis on an intention to
three (6%) patients because of a tight stenosis which treat principle. This analysis revealed a restenosis-free
did not allow catherisation. Two of these later under- interval of 60% after 48 months (SEE 9%) in the CPTA
went CEA whereas the third was treated medically group. In the CPTA with stent group the shorter
with aspirin and dipyridamole which he had not observation period only allowed calculation of a re-
recieved earlier. In another patient the artery recoiled stenosis-free interval of after 9 months which was 79%
after PTA. He became symptomatic with episodes of (SEE 11%) (Fig. 1).
TIA and was treated with CEA. In one patient the
endovascular stent occluded on the fourth day causing
transient neurologic symptoms but thereafter he be-
Discussioncame asymptomatic.
The perioperative CPTA mortality (30 days) was
CEA is considered the gold standard for treatment ofzero. Neurological events were recorded in ten (18%)
ICA lesions to reduce the risk of stroke in patientspatients during or immediatedly following the en-
with a symptomatic significant stenosis.2,8 With time,dovascular procedure. One patient (2%) had an epi-
however, the technical improvements have increasedsode of amaurosis fugax, and six (11%) had episodes
the use of endovascular treatments of these lesions.of TIA. Two (4%) patients suffered a minor stroke and
CPTA with or without stent deployment, has beenone (2%) a major stroke. In addition, six (11%) patients
used to treat both symptomatic and asymptomaticwere treated succesfully with intravenous atropin be-
arteriosclerotic lesions in the common carotid and ICAcause of bradycardia during the procedure and one
since 1979.9 The main concern with the technique haspatient was shortly unconcious presumably due to
been the risk of cerebral embolic episodes.cerebral hypoperfusion because the contralateral ICA
The combined incidence of mortality and majorwas occluded.The rate of neurological events was
stroke from endovascular treatment of ICA lesionssimilar in the initial (5 events/24 procedures) and late
varies between 1–9%.9–14 Kritpracha and Beebe re-periode (5 events/30 procedures) after the introduction
viewed and summarised experiences of 14 non-ran-of the CPTA in our department.
domised and non-controlled studies and did not draw
any conclusion because many series did not provide
adequate information about the patients, the in-
dications for treatment, the complications or the fol-Late outcome
low-up time. Their short report, however, revealed
that mortality and morbidity accounts for up to 30%After a median follow-up of 34 months (range 1–80
months), 40 (87%) patients were asymptomatic and and the risk of neurological deficits seems to be less
after stent deployment compared with PTA alone.15six (13%) had symptoms: TIA+amaurosis fugax (n=
1), TIA alone (n=4) or major stroke (n=1) (Table 1). One of the two randomised studies so far, the CA-
VATAS investigation, as yet unpublished, found aColour duplex sonography (45 cases) revealed that
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Table 1. Neurological events during follow-up (1–80 months). Forty-six patients
at risk. There was a longer follow up in the group with CPTA alone. Two patients
had symptoms without an ICA restenosis.
Neurological symptoms No symptoms
(AF–TIA–STROKE)
CPTA alone (n=31) 5 26
PTA+stent (n=15) 1 14
Total 6 40
% 11 87
Table 2. Result of the duplex scanning at follow-up. (1–80 months, 45 patients at risk).
Restenosis Restenosis Occlusion
0–70% >70%
CPTA alone (n=31) 22 8 1
CPTA+stent (n=14) 11 2 1
Total 33 10 2
% 73% 22% 5%
found a combined risk of death or major stroke of
3.1% while the risk increased to 5.8% if minor stroke
was included.2 The incidence of transient neurological
events (TIA and amaurosis fugax), however, was con-
siderably higher in our study than has been reported
in most previous studies. One reason for this difference
could be selection bias since many investigators in-
cluded 40–60% asymptomatic patients with severe ICA
lesions.13,14
At the beginning of our study period we only used
stents when the results of CPTA were sub-optimal,
e.g. recoil, dissection or irregular vessel wall. We later
changed our strategy, like others, and used stents
more routinely.1,3,20 A stent may reduce the risk of
microembolisation, residual stenosis and possibly also
the rate of restenosis.1,3,14,20–22 The procedural time dur-
ation of stent placement is short and consequently the
risk of cerebral ischaemia due to interruption of blood
flow is reduced.5
Various types of stents have been used in the ICA.
We used the balloon expandable Palmaz stent (Johnson
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Fig. 1. Calculation of the restenosis-free interval by use of Kaplan– and only the self expandable Easy Wallstent
Meier survival analysis in patients treated with CPTA alone or
(Schneider) for the last years. The thermosensitiveCPTA and stent (Intention to treat principle). All patients except
three (the one who died and the two who refused to participate) self expandable nitinol stents are the preferred stents
were included in the analysis. by interventional radiologists in other vascular ter-
ritories.9,11,14,23 These stents are flexible, have a low
thrombogenecity, a tight mesh and are transparent.combined risk of stroke (major and minor) and death
The Palmaz stent is made from stainless steel. Becausehigher than 10% after angioplasty and concluded that
it is rigid and needs dilatation from a balloon it mayangioplasty is as safe as surgery.16–18 The second ran-
result in microembolisation.9 Deformation of the Pal-domised study from Leicester has been suspended
maz stent from external compression has been de-because 5 of the 7 patients who who underwent CPTA
scribed in the literature with an incidence of stenthad a stroke.18,19
collapse between 1% and 16%.9,11,14,23 Therefore, we doOur results reveal a death and stroke rate (major
and minor) of 5%. In comparison, the NASCET study not use it any more.
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Although attempts with protection balloons and comparable with previous published results. Still, the
rate of transcient neurological events was high andfilters have been introduced to reduce the risk of
the incidence of restenosis was higher than has beenmicroembolisation to the brain during CPTA, we do
reported previously. Despite the advantages of CPTAnot yet take such precautions. Whether these pre-
and the fact that CPTA is less invasive than surgerycautions will reduce the incidence of neurological
there are still doubts regarding its safety and efficiency.complications following endovascular treatment re-
CPTA remains an experimental treatment and onemains to be investigated. In any case, such treatment
must clarify the indications of its use if we will offernecessitates that a guidewire and an occlusion balloon
patients with severe symptomatic stenosis of the ICAor filter is placed through the stenosis which in itself
a treatment which is as safe as CEA.may result in emboli.24 Furthermore, the occlusion
balloon, while inflated, causes a prolonged period of
decreased cerebral perfusion.
We catheterised all our patients through the femoral
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